NewcelX Stock (NASDAQ:NCEL)
Previous Close
$3.25
52W Range
$1.83 - $24.60
50D Avg
$3.57
200D Avg
$3.11
Market Cap
$1.52M
Avg Vol (3M)
$19.28K
Beta
0.93
Div Yield
-
NCEL Company Profile
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.